FDA Approves Imbruvica Label Expansion to Include Oral Suspension Formulation

New label marks the first Bruton’s tyrosine kinase inhibitor to be approved with an oral suspension formulation.

Source link
#FDA #Approves #Imbruvica #Label #Expansion #Include #Oral #Suspension #Formulation